Concepedia
Statistics
Publications
30
Citations
1.4K
H-Index
23
Active since
2011
Affiliations
Fuzhou University(Current)
Fujian Medical University
Beth Israel Deaconess Medical Center
Rutgers, The State University of New Jersey
Translational Therapeutics (United States)
Jichuang Wang is an author at Fuzhou University specializing in oncology, medicine, and pharmacology.
Publications per year
2011–2021
In vitro and in vivo anticancer activity evaluation of ursolic acid derivatives
Jingwei Shao, Yongchao Dai, Jinping Xue et al. · European Journal of Medicinal Chemistry · 2011 · 128 citations
Medicine, Oncology, Pharmacology +9
Pin1 inhibition reverses the acquired resistance of human hepatocellular carcinoma cells to Regorafenib via the Gli1/Snail/E-cadherin pathway
Jichuang Wang, Nan Zhang, Qi Han et al. · Cancer Letters · 2018 · 109 citations
Medicine, Oncology, Pharmacology +16
Nitric Oxide Inhibits Hetero-adhesion of Cancer Cells to Endothelial Cells: Restraining Circulating Tumor Cells from Initiating Metastatic Cascade
Yusheng Lu, Ting Yu, Haiyan Liang et al. · Scientific Reports · 2014 · 76 citations · Full text
Medicine, Oncology, Pharmacology +17
A novel controlled release formulation of the Pin1 inhibitor ATRA to improve liver cancer therapy by simultaneously blocking multiple cancer pathways
Dayun Yang, Wensong Luo, Jichuang Wang et al. · Journal of Controlled Release · 2017 · 75 citations · Full text
Pharmacy, Oncology, Pharmacology +16
Synergism of ursolic acid derivative US597 with 2-deoxy-D-glucose to preferentially induce tumor cell death by dual-targeting of apoptosis and glycolysis
Jichuang Wang, Jiang Zhou, Liping Xiang et al. · Scientific Reports · 2014 · 72 citations · Full text
1–5 of 30